Validated, tissue-specific library enables customisable and controllable liver-targeted gene expression with high specificity and minimal off-target activity in muscle tissue ...
Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class ...
OGM was selected as a genome-wide, unbiased method to detect large genomic rearrangements and structural variants (SVs) with sensitivity to variant allele fractions (VAFs) as low as 5% to analyze ...
While most research groups rely on organs from cloned, gene-edited pigs created through somatic cell nuclear transfer for pig-to-human transplantation, scientists at the Center for Innovative Medical ...
The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel ...
On Tuesday, 3304 stocks advanced, 981 declined and 151 remained unchanged on Bombay Stock Exchange with advance decline ratio of 3.36 indicating a positive closing. Today, nearly 536 stocks gained ...
The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel Therapeutic ...
The FDA AMT designation verifies NanoMosaic platform's ability to enhance efficiency, product quality, and scalability across AAV gene therapy manufacturing.
Demeetra AgBio, a genome engineering company enabling research and biomanufacturing through advanced gene-editing technologies and engineered CHO host cells, announced the completion and full ...
Belief Biomed Congratulates Partner Askbio On IND Acceptance By FDA For Investigational Gene Therapy For Late-Onset Pompe Disease. SHANGHAI, Jan. 14, 2026 /PRNewswire/ -- AskBio Inc. (AskBio), a gene ...
Professor Susan Sharfstein (University at Albany) discusses advances in cell line development, from high-throughput screening to transcription-based selection. Maren Grün (Thermo Fisher Scientific) sh ...
The company is advancing TG4050 in head and neck cancer and possibly to other tumor types based on encouraging Phase I data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results